Juha Punnonen

Company: Hinge Bio, Inc.

Job title: Chief Development Officer

Seminars:

Advancing B Cell Depletion Without T-Cells: Leveraging GEM-DIMER Technology to Mitigate Cytokine Toxicity in Autoimmunity 11:30 am

Designing T-cell-independent bispecifics for autoimmune B cell depletion to avoid key TCE-associated liabilities Demonstrating potent B cell depletion and favourable safety in NHP in vivo Positioning for autoimmune indications where reduced cytokine release is essential for patient tolerabilityRead more

Advancing B Cell Depletion Without T-Cells: Leveraging GEM-DIMER Technology to Mitigate Cytokine Toxicity in Autoimmunity 11:30 am

Designing T-cell-independent bispecifics for autoimmune B cell depletion to avoid key TCE-associated liabilities Demonstrating potent B cell depletion and favourable safety in NHP in vivo Positioning for autoimmune indications where reduced cytokine release is essential for patient tolerabilityRead more

day: Day Two